Canadian Pacific Kansas City Limited Common Shares vs Pfizer Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while Pfizer Inc trades at $27.78 (market cap $159.59B). The key difference: Pfizer Inc is far larger — about 2.2× Canadian Pacific Kansas City Limited Common Shares's market cap, and Pfizer Inc pays the higher dividend (6.14%). Which is the better fit depends on your goals.
| CP | PFE | |
|---|---|---|
Market Cap | $73.71B | $159.59B |
Volume | 2,143,178 | 30,937,010 |
Sector | Industrials | Health |
52-Week High | $96.69 | $29.02 |
52-Week Low | $68.88 | $23.67 |
Enterprise Value | $91.14B | $211.09B |
Dividend Yield | 0.91% | 6.14% |
Typical Hold Time | — | 158 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →